LABU / LABD Ratio Anchored VWAP over /under LABU LONG

2024年2月15日

On the weekly chart a LABU / LABD ratio is plotted with anchored VWAP bands and a volume

profile overlaid. I wanted to analyze this to affirm the highest of prospects for the

Biotechnology sector for 2024. LABU is triple leveraged Up while LABD is the inverse Down.

A good unleveraged biotech ETF is XBI. The chart shows LABU in a VWAP band and breakout

through the hohg volume area and then over it beginning early November. Unusually high

relative volume and volatility ramped up about the same time.

I readily conclude that LABU is the buy right now with the ratio rising. It is a low beat ETF

with good range due to the leveraging and high forecasts for 2024. I will make buys on

LABU at regular intervals on a 60-120 minute time frame looking for the weekly lows.

I will set an alert for a falling ratio on the 3H to daily chart to assess should the supertrend

fade. I believe that this will be a safe low risk swing long trade.

2024年2月15日

交易开始

Trade plan zoomed in linked here:

2024年2月15日

交易开始

This is a falling wedge breakout and fade with recovery upside

2024年2月15日

注释

It could end up making another falling wedge which remains to play out or not.

2024年2月15日

交易开始

LABu up today and the ratio rises as expected.

2024年2月17日

交易开始

Ratio is sideways at this time